Hyderabad (Telangana) [India], September 16 (ANI): The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited on Tuesday announced a collaboration to develop vaccines for COVID-19.
New Delhi [India], September 15 (ANI): Three COVID-19 vaccines are at a clinical trial stage in the country and two indigenous vaccine candidates have completed phase one trial, Indian Council of Medical Research (ICMR) DG Dr Balram Bhargava said on Tuesday.
Mumbai (Maharashtra) [India], Sep 15 (ANI): Equity benchmark indices closed with an upward bounce on Tuesday as a sharp rally was witnessed in select mid-cap stocks for the second consecutive trading session.
Moscow [Russia], September 15 (ANI/Sputnik): Over 300 volunteers have been inoculated during the post-registration trials of Russia's COVID-19 vaccine, dubbed Sputnik V, around 14 percent of them have reported fatigue, muscle pain or high body temperature, Russian Health Minister Mikhail Mur
Mumbai (Maharashtra) [India], September 15 (ANI): Equity benchmark indices traded higher with narrow gains during early hours on Tuesday amid positive sentiment across global markets.
Mumbai (Maharashtra) [India], September 14 (ANI): Equity benchmark indices traded firm during early hours on Monday on the back of positive global cues as hopes of a coronavirus vaccine were rekindled after AstraZeneca resumed its phase three trial.
Madrid [Spain], September 14 (ANI): Spain's first trials of a coronavirus vaccine are scheduled to begin on September 14, Alberto Borobia, the chief of the clinical trials unit of the La Paz University Hospital in Madrid, said on Sunday.
New Delhi [India], September 13 (ANI): The COVID-19 vaccine might be ready by the first quarter of 2021, Union Health Minister Dr Harsh Vardhan said on Sunday.
Tehran [Iran], September 13 (ANI/Xinhua): Iranian medical scientists will soon start human trials for an anti-coronavirus vaccine after the stage of animal trials has passed, official news agency IRNA reported on Saturday.
Moscow [Russia], September 13 (ANI): Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev on Saturday said that temporary suspension of AstraZeneca COVID-19 vaccine candidate trials clearly showed the "fallacy of the approach" when countries "exclusively rely on novel and untested platf
New Delhi [India], September 13 (ANI): Principal Secretary to Prime Minister Dr PK Mishra on Saturday chaired a high-level meeting to review COVID-19 preparedness and response.
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives